Effect and mechanism of Irbesartan on occurrence of ventricular arrhythmias in rats with myocardial ischemia through connexin43 (cx43)  by Wu, Tao et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(10): 1007–1012 1007Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2016.07.022✉First and corresponding author: Tao Wu, Department of Cardiovascular Med-
icine, the Second Afﬁliated Hospital of Nanchang University, No.1 Minde Road,
Nanchang 330006, Jiangxi Province, China.
Tel: +86 13507910760, +86 0791 86312561
E-mail: wuwuta10@163.com
Peer review under responsibility of Hainan Medical University.
Foundation Project: It was supported by Research Topic of Department of Health
of Jiangxi Province (No. 20131074) and Natural Science Fund of Jiangxi Province
(No: 20122BAB205028).
1995-7645/Copyright © 2016 Hainan Medical University. Production and hosting by Elsevier B.V. This is an open access a
creativecommons.org/licenses/by-nc-nd/4.0/).Effect and mechanism of Irbesartan on occurrence of ventricular arrhythmias in rats with myocardial
ischemia through connexin43 (cx43)Tao Wu1✉, Dan Wu2, Qinghua Wu1, Bing Zou1, Xiao Huang1, Xiaoshu Cheng1, Yanqing Wu1, Kui Hong1, Ping Li11Department of Cardiovascular Medicine, the Second Afﬁliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China
2Jiangxi Health Vocational College, Nanchang 330052, Jiangxi Province, ChinaARTICLE INFO
Article history:
Received 19 May 2016
Received in revised form 20 Jun 2016
Accepted 19 Jul 2016
Available online 10 Aug 2016
Keywords:
Irbesartan
Myocardial ischemia
Cx43
Connexin
ArrhythmiasABSTRACT
Objective: To explore the effect and mechanism of angiotensin II receptor blockers –
Irbesartan on occurrence of ventricular arrhythmias in rats with myocardial ischemia.
Methods: Rats with embryonic cardiomyocytes-H9c2 were randomly divided into control
group, ischemia group, Irbesartan group and Irbesartan + ischemia group. The cell viability
of rats in each group was tested using MTT. Real-time PCR was employed to detect the
expression of connexin43 (Cx43) mRNA and western blot to detect the expression of Cx43
and phosphorylated Cx43. SD rats were randomly divided into the sham-operation group
(SO), myocardial infarction group (MI), Irbesartan group and MI + Irbesartan group, with
10 rats in each group. HE staining was employed to observe the change in the patho-
morphology of left ventricular tissue and TUNEL method to analyze the cell apoptosis in
the tissue. The immunoﬂuorescence was adopted to observe the expression and distribution
of Cx43 in the left ventricular myocardium and study the change in the expression of Cx43
in the cardiac muscular tissue at mRNA and protein level.
Results: The intervention of Irbesartan in the condition of ischemia indicated the signiﬁcant
decrease in the number of necrotic cells. The expression of Cx43was signiﬁcantly decreased
under the culture of ischemia (P < 0.05), but in the presence of Irbesartan, the expression of
Cx43 was increased compared with the ischemia group (P< 0.01). The results ofWB assay
showed the similar trend of change at mRNA level. There was the signiﬁcant difference in
the score of ventricular arrhythmia between MI group and SO group (P < 0.01). The inci-
dence of ventricular tachycardia or ventricular ﬁbrillation was signiﬁcantly increased
compared with the one in SO group (P < 0.05). There was the signiﬁcant difference in the
overall score between MI + Irbesartan group and MI group (P < 0.05). The expression of
Cx43 in the cardiacmuscular tissue inMI groupwas signiﬁcantly decreased (P< 0.01 vs SO
group). But the expression of Cx43 was increased after the treatment with Irbesartan.
Conclusions: Irbesartan can inhibit the injury of H9c2 cardiomyocytes and the decreased
expression of Cx43 that are induced by the ischemic myocardial infarction. Irbesartan can
also improve the reconstruction of Cx43 in rats with ischemic myocardium to inhibit the
myocardial infarction-induced arrhythmias.1. Introduction
The ventricular arrhythmias refer to the cardiac arrhythmia
that is rooted in the ventricle, as the common arrhythmia.Arrhythmias can be found in patients without the organic heart
diseases and with the severe heart diseases because of myocar-
dial ischemia. The previous research indicated that, in the con-
dition of myocardial ischemia and hypoxia, the incidence of
ventricular arrhythmias was signiﬁcantly increased, which might
even cause the death of cardiomyocytes. The death of car-
diomyocytes because of myocardial ischemia was also the sig-
niﬁcant cause for the death of patients with cardiovascular
diseases [1].
The connexin (Cx) is the family of membrane proteins that
form the intercellular gap junction to play the role of signal
communication. Cx was also of critical signiﬁcance in regulatingrticle under the CC BY-NC-ND license (http://
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According to the previous researches, there were abundant gap
junctions between the cardiomyocytes and smooth muscle
cells and the abnormal change in the gap connection could
cause the cardiovascular diseases [3,4]. The connexin43 (Cx43)
is one of connexins in the gap connection of interdiac
structure of cardiomyocytes. The normal expression and
distribution of Cx43 were of critical importance to maintain
the normal function of myocardial connection and heart [5–7].
The Irbesartan is the receptor inhibitor of Angiotensin II (Ang
II), which can inhibit the transformation of Ang I into Ang II. As
the new long-acting angiotensin antagonist, it could be used in
the clinical treatment of hypertension and congestive heart failure
[8], which could increase the threshold of ventricular ﬁbrillation
during the ischemia and reduce the occurrence times and
incidence of ventricular tachycardia and ventricular ﬁbrillation
because of myocardial ischemia [9,10]. The research also
indicated that, Angiotensin II could induce the hypertrophy of
cardiomyocytes and signiﬁcantly reduce the expression of
Cx43, which might be related to the change in the cell cycle
during the myocardial hypertrophy. But there have been limited
studies on the issue whether Irbesartan can affect the
expression and distribution of Cx43 and thus improve the
injury of cardiac muscular tissue so far. Therefore, it has the
certain clinical signiﬁcance to study the effect of Irbesartan on
the expression of Cx43 and the mechanism of ventricular
arrhythmias that is caused by myocardial ischemia.
In this study, based on the serum-free culture of rat car-
diomyocytes-H9c2 and the modeling of myocardial ischemia,
the expression of Cx43 in rats in the condition of myocardial
ischemia was explored at the cellular and animal level. Besides,
the effect of Irbesartan on the expression of Cx43 in the cardiac
muscular tissue and its possible mechanism were discussed, in
order to provide the reference for the prevention and reduction of
ventricular tachycardia.
2. Materials and methods
2.1. Reagents and instruments
Rats with cardiomyocytes-H9c2 was purchased from ATCC
and conserved in this laboratory; SPF (4–8) week male SD rats,
with the weight of (200–230) g, were provided by Laboratory
Animal Center of Nanchang University and approved by Medical
Research Ethics Committee of The Second Afﬁliated Hospital to
Nanchang University; Irbesartan tablets were purchased from
Xiuzheng Pharmaceutical Group Co., Ltd.; DMEM medium from
Hyclone (USA); the fetal bovine serum fromGIBCO (USA); RNA
extraction kit from QIAGEN (Germany); the reverse transcription
kit from Applied Biosystems (USA); Real-time PCR ﬂuorescence
quantitative kit from Applied Biosystems (USA); ReadyPrep
protein extraction kit from Bio-Rad (USA); MTT cell proliferation
assay kit from Beyotime Biotechnology; protein assay kit from
Vazyme Biotech (China); horseradish peroxidase (HRP) labeled
secondary antibodies from Beijing Zhongshan Jinqiao Biotech-
nology; 0.22 mm PVDF membrane from Millipore (USA); ECL
chemiluminescence assay kit from Millipore (USA); the immu-
noﬂuorescence kit from Beyotime Biotechnology; Tunel assay kit
from Vazyma (USA); rabbit anti-rat CX43, p-CX43 and b-actin
monoclonal antibody from Abcam (UK).
The animal ECG measurement and analysis system was
ECGenie; the ﬂuorescence inverse microscope was Beckman;the quantitative protein and nucleic acid analyzer was Nanodrop
2000; the ﬂuorescence quantitative PCR was Applied Bio-
systems 7500; XD-2A heart diagnosis and treatment instrument
was purchased from Suzhou Dongfang Instrument Factory.
2.2. Methods
2.2.1. Cell culture and grouping
After the recovery of rat cardiomyocytes-H9c2, the cells were
resuspended in DMEM medium and then put in the incubator at
37 C and with 5% CO2 for the culture. Cells were randomly
divided into the control group, ischemia group, Irbesartan group
and Irbesartan + ischemia group. Forty-eight hours after the
serum-free culture, MTT was employed to detect the cell
viability. After extracting the total RNA, Real-time PCR was
used to detect the expression of Cx43 at mRNA level. BCA
assay was adopted to measure the concentration of total protein
and detect the expression of Cx43 and phosphorylated Cx43.
2.2.2. Real-time PCR
The total RNA was extracted by RNA extraction kit and then
transcripted reversely into cDNA. Real-time PCR was employed
to detect the expression of related genes. The mRNA sequence of
gene could be referred to NCBI database and then the Real-time
PCR primers could be designed. All primers were synthesized by
Shanghai Sangon Biotech, with the speciﬁc sequence shown as
follows: Cx43 (NM_010288.3): For: ACAAGGTCCAAGCC-
TACTCCA; Rev: CCGGGTTGTTGAGTGTTACAG, GAPDH
(NM_008085): For: AATGGATTTGGACGCATTGGT; Rev:
TTTGCACTGGTACGTGTTGAT. The double △△Ct method
was adopted to calculate the relative expression of target gene: the
mean of three repeats was treated as the CT value of each sample,
△CT = CT (Target Gene) − △CT (reference), △△CT = △CT
(sample) − △CT (contro1). Therefore, the relative expression of
target gene = 2−△△CT and the relative expression of control
group was 20 = 1 [11]. The PCR system (20 mL) was: 2×SYBR
Fast qPCR Mix: 10 mL; PCR Forward/Reverse Primer
(10 mM): 1 mL; cDNA template: 2 mL. The reaction
parameters were: Holding Stage 95 C for 33 s, Cycling Stage
95 C for 3 s, 60 C for 12 s, Cycles = 40.
2.2.3. Western blot
ReadyPrep protein extraction kit was used to extract the
total protein and BCA kit to detect the concentration of pro-
tein. After SDS-PAGE electrophoresis for 20 mg total protein
samples, the gel was transferred into membrane. The primary
antibody with the appropriate degree of dilution was added for
the incubation at the room temperature for 2 h. The membrane
was incubated with the secondary antibody that was diluted
with TBS/T (1:10000, HRP-labeled) at the room temperature
for 1 h. It was exposed and then photographed to save the
experimental results. Quantity one v4.62 was used to measure
the gray value of molecular band (trace tracking). The semi-
quantitative value of target protein/reference protein was
treated as the quantitative foundation. The statistical analysis
was performed as well.
2.2.4. Modeling and grouping of rats with chronic
myocardial ischemia [12]
The laboratory animals were fed in the standard animal cage,
with 5 rats in each cage. Rats were given the diet and drinking
Table 1
Effect of Irbesartan on expression of Cx43 in ischemic cardiomyocytes
(mean ± SD).
Group OD value CX43/
GAPDH
(mRNA)
CX43/
GAPDH
(protein)
p-CX43/
CX43
Control 0.78 ± 0.08 1.00 ± 0.10 0.81 ± 0.08 0.78 ± 0.07
Irbesartan 0.80 ± 0.08 1.18 ± 0.11 0.87 ± 0.08 0.83 ± 0.08
Ischemia 0.43 ± 0.04** 0.28 ± 0.02** 0.42 ± 0.04** 0.40 ± 0.04**
Irbesartan
+ Ischemia
0.62 ± 0.06## 0.63 ± 0.06## 0.70 ± 0.07## 0.67 ± 0.07##
**P < 0.01 compared with control group; ##P < 0.01 compared with
ischemia group.
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feeding room and natural lighting day and night. The room
temperature was maintained at (18–25) C, with the humidity of
50%–60%. There were randomly divided into the sham-
operation group (SO) (10 rats), with the threading below the
left anterior descending (LAD) and without ligation; myocardial
ischemia group (MI) (10 rats); Irbesartan group (10 rats); and
myocardial ischemia + Irbesartan group (MI + Irbesartan) (10
rats). Rats were given the intraperitoneal injection of 2% chloral
hydrate for the anesthesia and then the endotracheal intubation
was connected to the ventilator [tidal volume of (4–8) mL,
respiratory ratio of 5:4 and respiratory frequency of 90 times/
min]. After ﬁnding the 3rd and 4th ribs at the left side of
breastbone, the chest was opened to expose the heart. The
middle and upper 1/3 part of left coronary artery was sutured.
The change in ECG characteristics was taken as the index to
conﬁrm the successful replication of model. After the operation,
rats were given the irrigation of Irbesartan at the dose of 30 mg/
kg/d. Rats in the control group were given the irrigation of
double distilled water at the same dose and fed with the normal
diet for 12 weeks.
The heart tissue was separated and the vessels at the atrio-
ventricular junction were cut off, with the free wall of atrial
myocytes. Only the cardiac muscular tissue of left ventricular
and left ventricular septum was remained. The cardiac muscular
tissue was cut along the longitudinal direction of muscle ﬁber.
Part of cardiac muscular tissue was ﬁxed with formaldehyde,
embedded in parafﬁn and stained with HE. Part of cardiac
muscular tissue was stored in −80 C refrigerator. The immu-
noﬂuorescence assay was performed according to the instruc-
tion manual of assay kit. The ﬂuorescence microscope was
employed to observe the speciﬁc ﬂuorescence intensity of
samples. The preparation and staining of TUNEL detection
liquid were performed according to the instruction manual of
assay kit. Image-Pro Plus 6.0 was employed to count the pos-
itive cells.
2.2.5. Echocardiographic assessment
Before the intervention and 12 weeks after the intervention of
Irbesartan, 10% chloral hydrate was used for the anesthesia. The
color Doppler ultrasonic diagnostic apparatus (high-frequency
probe) was employed to detect the Left ventricular posterior wall
thickness, interventricular septum thickness at end-systole, left
ventricular posterior wall thickness at end-diastole and inter-
ventricular septum thickness at end-diastole. The mean of ﬁve
continuous cardiac cycles was taken. The occurrence times of
ventricular arrhythmias for rats in three groups were monitored
15, 30, 45, 60, 75 and 90 d after the drug administration. The
rats with myocardial ischemia were selected and then they were
monitored by the continuous electrocardiogram to observe the
occurrence times of ventricular arrhythmias after the modeling
of myocardial ischemia, including the ventricular premature beat
(VP), ventricular tachycardia (VT) and ventricular ﬁbrillation
(VF). The ventricular tachycardia was deﬁned as the continuous
4 VPs or more. The arrhythmia was scored [13]: ventricular
premature beat (VP) 0 point: VP = 0 time; 1 point:
0 < VP  10 times; 2 points: 10 < VP  50 times; 3 points:
VP > 50 times; ventricular tachycardia (VT) −4 points:
VT = 1 time; 5 points: 2  VT  5 times; 6 points: VT > 5
times; ventricular ﬁbrillation (VF) −7 points: VF = 1 time; 8
points: 2  VF  5 times; 9 points: VF > 5 times.2.3. Data analysis
The data was treated with SPSS 11.5 and the results were
expressed by mean ± SD. The t test was employed for the
comparison between groups and P < 0.05 indicated the statis-
tical difference.
3. Results
3.1. Effect of Irbesartan on expression of Cx43 in
ischemic cardiomyocytes
H9c2 cardiomyocytes were randomly divided into the control
group, ischemia group, Irbesartan group and Irbesartan + ischemia
group. Eight hours after the serum-free culture, the phase-contrast
microscope was used to observe cells. It could be indicated that,
due to the deﬁciency of serum, the cellular morphology was
changed and the intercellular adhesion was disappeared, showing
the cell vacuolation. But the cells in the control group had the clear
boundary and normal morphology. After the intervention of
Irbesartan in the condition of ischemia, the number of necrotic cells
was signiﬁcantly decreased. The results of MTT assay also indi-
cated that the cell viability in the ischemia group was lowest, while
the cell viability in the Irbesartan group was increased by 44.19%.
Real-time PCR was employed to detect the expression of Cx43 in
mRNA. In the condition of ischemia culture, the expression of
Cx43was signiﬁcantly decreased (P< 0.05); while in the presence
of Irbesartan, the expression of Cx43was increased comparedwith
the ischemia group (P< 0.01). The western blot was used to detect
the expression of Cx43 and phosphorylated Cx43. The results
showed the similar trend of change at mRNA level, namely the
expression of Cx43 could be increased in the presence of Irbe-
sartan. Besides, the expression was also increased to the certain
extent at the phosphorylation level, with results shown in Table 1.3.2. Irbesartan to improve the ventricular arrhythmias
and expression of Cx43 in rats with ischemic
myocardium
A total of 40 male SD rats were randomly divided into the
SO group, MI group, Irbesartan group and MI + Irbesartan
group, with 10 rats in each group. The change in ECG charac-
teristics was taken as the index to conﬁrm the model of
myocardial ischemia. The ECG characteristics of rat model of
chronic myocardial ischemia had the abnormal decrease ac-
cording to the results of conductive poles of I, II, III, aVR, aVL
Table 3
Effect of Irbesartan on expression of Cx43 in ischemic cardiac muscular
tissue (mean ± SD).
Group CX43/GAPDH (mRNA) CX43/GAPDH (protein)
SO 0.72 ± 0.07 0.89 ± 0.09
Irbesartan 0.79 ± 0.08 0.32 ± 0.03
MI 0.29 ± 0.03** 0.93 ± 0.09**
MI + Irbesartan 0.67 ± 0.06## 0.60 ± 0.06##
*P < 0.05 compared with SO group; *P < 0.01 compared with SO group;
##P < 0.05 compared with MI group.
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modeling of myocardial ischemia.
After 12 weeks of treatment with Irbesartan, HE staining was
employed to observe the change in the pathological morphology
of left ventricular tissue. SO group showed the orderly
arrangement of cardiac muscle ﬁbers, with the clear horizontal
stripes. But MI group showed the patchy necrosis of car-
diomyocytes, karyopyknosis and karyorrhexis, unclear or dis-
appeared horizontal stripes and diffuse inﬁltration of
polymorphonuclear neutrophils. After 12 weeks of treatment
with Irbesartan, the cardiac muscle ﬁbers tended to be orderly
and the inﬁltration of polymorphonuclear neutrophils was
decreased.
The cardiac muscular tissue was separated in each group and
the tissue sections were prepared. TUNEL method was
employed to analyze the myocardial necrosis after the myocar-
dial ischemia. The staining was performed according to the in-
struction of kit and Image-Pro Plus 6.0 was used to count the
number of positive cells, where SO group: 18.24 ± 0.15; Irbe-
sartan group: 16.27 ± 1.59; MI group: 103.66 ± 12.35;
MI + Irbesartan group: 53.64 ± 7.06. There was the signiﬁcant
difference between MI group and SO group, MI + Irbesartan
group and MI group (P < 0.05), which could indicate that
Irbesartan could signiﬁcantly inhibit the myocardial necrosis of
rats with MI.
The echocardiography was employed to measure the cardiac
function. The rats with myocardial ischemia were selected and
then they were monitored by the continuous electrocardiogram
to observe the occurrence times of ventricular arrhythmias after
the modeling of myocardial ischemia, including VP, VT and VF.
The ventricular tachycardia was deﬁned as the continuous 3 VPs
or more, with results shown in Table 1. There was the signiﬁcant
difference in the score of ventricular arrhythmia between MI
group and SO group (P < 0.01). The incidence of ventricular
tachycardia or ventricular ﬁbrillation in MI group was up to 80%
(8/10), which was signiﬁcantly increased compared with SO
group (P < 0.05). There was the signiﬁcant difference in the
total score between MI + Irbesartan group and MI group
(P < 0.05), with results shown in Table 2.Table 2
Score of ventricular arrhythmia.
Group VP VT VF Total
SO 1.28 ± 0.68 3.28 ± 0.38 5.66 ± 0.58 10.09 ± 0.93
Irbesartan 0.34 ± 0.01 2.19 ± 0.28 4.57 ± 0.68 6.93 ± 0.61
MI 3.03 ± 0.36** 6.09 ± 0.27** 9.03 ± 0.31** 18.01 ± 0.23**
MI +
Irbesartan
3.01 ± 0.15## 4.14 ± 0.35## 7.65 ± 0.61## 14.78 ± 0.21##
*P < 0.05 compared with SO group; **P < 0.01 compared with SO
group; ##P < 0.05 compared with MI group.The immunoﬂuorescence was employed to detect the
expression of Cx43 in the cardiac muscular tissue of left
ventricle. The results indicated that the distribution of Cx43 in
SO group showed the end-to-end connection of cardiomyocytes
that was perpendicular to the long axis of cardiac muscle ﬁbers.
In the ischemia group, the discontinuous distribution of Cx43
showed the side-to-side connection that was parallel to the long
axis of cardiac muscle ﬁbers. The myocardial ischemia could
lead to the change in the distribution of Cx43. As shown inTable 3, the expression of Cx43 in the cardiac muscular tissue
was detected at mRNA and protein level respectively. The
expression of Cx43 in MI group was signiﬁcantly decreased. But
the expression of Cx43 was increased after the treatment with
Irbesartan, with the results shown in Table 3.4. Discussion
The cardiovascular diseases refer to the major diseases that
threaten the health of human life. The injury of cardiomyocytes
that is caused by the myocardial ischemia and hypoxia is
recognized as the focus in the cardiovascular diseases. The an-
imal model of myocardial ischemia is the key material to study
the cardiovascular diseases. The most common method in the
animal model of myocardial ischemia is the ligation of coronary
artery, generally the ligation of left anterior descending. Such
method has been widely applied because of the easy operation.
But there is the high mortality due to the ligation of coronary
artery during the modeling. For instance, the success rate of
modeling in this study was about 90%. Rats were suddenly died
of the surgical infection and heart arrest.
Ang II is a key enzyme in the renin-angiotensin system, with
the strong activity of vasoconstriction. It could be bound with
the receptor of Ang II to promote the vasoconstriction and
secretion of aldosterone to cause a great number of physiological
responses [14,15], which plays a key role in the pathogenesis of
hypertension, arterial diseases, cardiac hypertrophy, heart
failure, diabetes and kidney diseases. The Ang II receptor
inhibitors such as Irbesartan could inhibit the transformation
of Ang I into Ang II, speciﬁcally antagonize the conversion of
angiotensin into AT1 receptor and stop the bounding between
Ang II and ATl receptor to mitigate the myocardial injury
[16,17]. It has the functions of resisting the ischemia
arrhythmias, relieve the myocardial stunning and reduce the
infarction size. According to the results of pathomorphology
in this study, the sham-operation group showed the orderly
arrangement of cardiac muscle ﬁbers, with the clear horizontal
stripes. But the ischemia model group showed the severe injury
of tissue, unclear cell boundaries, broken muscle ﬁber, dis-
appeared horizontal stripes and inﬁltration of poly-
morphonuclear neutrophils. After 12 weeks of treatment with
Irbesartan, the cardiac muscle ﬁbers tended to be orderly with
the clear boundaries and the inﬁltration of polymorphonuclear
neutrophils was decreased. The TUNEL method was employed
to analyze the myocardial necrosis after the myocardial
ischemia. The results indicated that the apoptosis of car-
diomyocytes was signiﬁcantly increased in rats with myocardial
ischemia (P < 0.05). The intervention of Irbesartan could inhibit
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ischemia. The pathways that were involved in the process of
Irbesartan to inhibit the apoptosis of cardiomyocytes included
Bcl-2, bax, Fas/FasL and p-53 [18].
The previous researches indicated the change in the gap
junctions in many pathological cardiac tissues and such change
was related to the susceptibility of arrhythmias. The myocar-
dial gap junction is also named as the communication junction,
which is composed of Cx. There are mainly three kinds of Cx
in human body, namely Cx43, Cx40 and Cx45 [19,20]. In this
study, it also found the signiﬁcant decrease in the expression
of Cx43 in the condition of ischemia culture (P < 0.05);
while the expression of Cx43 was signiﬁcantly increased in
the presence of Irbesartan compared with the ischemia group
(P < 0.01). It indicated the signiﬁcant change in the
expression of Cx43 in the process of cardiomyocytes injury
because of ischemia. The expression of Cx43 in the cardiac
muscular tissue was detected at mRNA and protein level
respectively. Where, the expression of Cx43 in MI group
was signiﬁcantly decreased (P < 0.01 vs SO). After the
treatment with Irbesartan, the expression of Cx43 was
increased. Cx43 may be involved in the inhibition of injury
because of myocardial ischemia by Irbesartan. The
immunoﬂuorescence was employed to detect the expression
of Cx43 in the cardiac muscular tissue of left ventricle. The
results indicated that the distribution of Cx43 in SO group
showed the end-to-end connection of cardiomyocytes that
was perpendicular to the long axis of cardiac muscle ﬁbers. In
the ischemia group, the discontinuous distribution of Cx43
showed the side-to-side connection that was parallel to the
long axis of cardiac muscle ﬁbers. The myocardial ischemia
could lead to the change in the distribution of Cx43. According
to the study at the cellular level, the expression of Cx43 was
increased in the presence of Irbesartan. Besides, the expression
of Cx43 was also increased to the certain extent at the phos-
phorylated level, which indicated that in the condition of
myocardial ischemia, the activity of Cx43 was inhibited and
thus its subcellular localization was changed. In the process
that Irbesartan inhibited the injury of cardiomyocytes through
Cx43, it plays the key role of regulation in the expression of
Cx43 and its activation. But the speciﬁc molecular mechanism
has not been clear yet.
In the study of arrhythmia, the echocardiography was
employed to measure the cardiac function. The rats with
myocardial ischemia were selected and then they were
monitored by the continuous electrocardiogram to observe the
occurrence times of ventricular arrhythmias after the modeling
of myocardial ischemia. The results indicated that there was
the signiﬁcant difference in the score of ventricular
arrhythmia between MI group and SO group (P < 0.01). The
incidence of ventricular tachycardia or ventricular ﬁbrillation
in MI group was up to 80%, which was signiﬁcantly increased
compared with SO group (P < 0.05). There was the signiﬁcant
difference in the total score between MI + Irbesartan group
and MI group (P < 0.05). It indicated that the intervention
treatment of Irbesartan can reduce the occurrence of
arrhythmia.
Conﬂict of interest statement
We declare that we have no conﬂict of interest.References
[1] Abdel-Kawy HS. Chronic pantoprazole administration and
ischemia-reperfusion arrhythmias in vivo in rats-antiarrhythmic or
arrhythmogenic? Cardiovasc Ther 2015; 33(2): 27-34.
[2] Schulz R, Go¨rge PM, Go¨rbe A, Ferdinandy P, Lampe PD,
Leybaert L. Connexin 43 is an emerging therapeutic target in
ischemia/reperfusion injury, cardioprotection and neuroprotection.
Pharmacol Ther 2015; 153: 90-106.
[3] Goodenough DA1, Goliger JA, Paul DL. Connexins, connexons,
and intercellular communication. Annu Rev Biochem 1996; 65:
475-502.
[4] Ueda N, Yamamoto M, Honjo H, Kodama I, Kamiya K. The role
of gap junctions in stretch-induced atrial ﬁbrillation. Cardiovasc
Res 2014; 104(2): 364-370.
[5] Dhillon PS, Chowdhury RA, Patel PM, Jabr R, Momin AU,
Vecht J, et al. Relationship between connexin expression and gap-
junction resistivity in human atrial myocardium. Circ Arrhythm
Electrophysiol 2014; 7(2): 321-329.
[6] Fry CH, Gray RP, Dhillon PS, Jabr RI, Dupont E, Patel PM, et al.
Architectural correlates of myocardial conduction: changes to the
topography of cellular coupling, intracellular conductance, and
action potential propagation with hypertrophy in Guinea-pig ven-
tricular myocardium. Circ Arrhythm Electrophysiol 2014; 7(6):
1198-1204.
[7] Rodríguez-Sinovas A, Sa´nchez JA, Fernandez-Sanz C, Ruiz-
Meana M, Garcia-Dorado D. Connexin and pannexin as modula-
tors of myocardial injury. Biochim Biophys Acta 2012; 1818(8):
1962-1970.
[8] Grall S, Biere L, Le Nezet M, Bouvier JM, Lucas-Chauvelon P,
Richard C, et al. Relationship between beta-blocker and
angiotensin-converting enzyme inhibitor dose and clinical outcome
following acute myocardial infarction. Circ J 2015; 79(3): 632-
640.
[9] Ceker Z, Takmaz SA, Baltaci B, Bas¸ar H. The effect of esmolol on
corrected-QT interval, corrected-QT interval dispersion changes
seen during anesthesia induction in hypertensive patients taking an
angiotensin-converting enzyme inhibitor. Rev Bras Anestesiol
2015; 65(1): 34-40.
[10] Smith AH, Flack EC, Borgman KY, Owen JP, Fish FA,
Bichell DP, et al. A common angiotensin-converting enzyme
polymorphism and preoperative angiotensin-converting enzyme
inhibition modify risk of tachyarrhythmias after congenital heart
surgery. Heart Rhythm 2014; 11(4): 637-643.
[11] Livak KJ, Schmittgen TD. Analysis of relative gene expression
data using real-time quantitative PCR and the 2(−Delta Delta C(T))
method. Methods 2001; 25(4): 402-408.
[12] Fu P, Niu TS, Jiang CL. One method of model establishment of
chronic myocardial infarction in rats. Chin J Comp Med 2006;
16(5): 295-297.
[13] Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Beurrier D,
de Chillou C, et al. Recurrences of symptoms after AV node re-
entrant tachycardia ablation: a clinical arrhythmias risk score to
assess putative underlying cause. Int J Cardiol 2015; 179: 292-296.
[14] Li W, Lv J, Wu J, Zhou X, Jiang L, Zhu X, et al. Maternal high-salt
diet altered PKC/MLC20 pathway and increased ANG II receptor-
mediated vasoconstriction in adult male rat offspring. Mol Nutr
Food Res 2016; 60(7): 1684-1694.
[15] Xu R, Cai A, Zheng D, Qiu R, Li L, Zhou Y, et al. Amlodipine
suppresses Ang-II-induced endothelium dysfunction by diminish-
ing ROCK1 expression. Clin Exp Hypertens 2016; 38(2). 166–
1672.
[16] Maeda A, Tamura K, Wakui H, Ohsawa M, Azushima K,
Uneda K, et al. Effects of Ang II receptor blocker irbesartan on
adipose tissue function in mice with metabolic disorders. Int J Med
Sci 2014; 11(6): 646-651.
[17] Xue B, Thunhorst RL, Yu Y, Guo F, Beltz TG, Felder RB, et al.
Central renin-angiotensin system activation and inﬂammation
induced by high-fat diet sensitize angiotensin II-elicited hyperten-
sion. Hypertension 2016; 67(1): 163-170.
Tao Wu et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(10): 1007–10121012[18] Jugdutt BI, Menon V. AT1 receptor blockade limits myocardial
injury and upregulates AT2 receptors during reperfused myocardial
infarction. Mol Cell Biochem 2004; 260(1–2): 111-118.
[19] Lin X, Xu Q, Veenstra RD. Functional formation of heterotypic
gap junction channels by connexins-40 and -43. Channels (Austin)
2014; 8(5): 433-443.[20] Rackauskas M, Kreuzberg MM, Pranevicius M, Willecke K,
Verselis VK, Bukauskas FF. Gating properties of heterotypic gap
junction channels formed of connexins 40, 43, and 45. Biophys J
2007; 92(6): 1952-1965.
